118 results on '"Lanza, A. Galeota"'
Search Results
2. Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrence
3. El social building en tiempos de pandemia.
4. Trends in liver transplantation for primary sclerosing cholangitis.
5. Review of: "Alas (Hellas), there is no hope: It’s not a crisis, it’s a culture"
6. Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: Risk of HCC recurrence from a large, multicentre retrospective study from Italy
7. Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: risk of HCC recurrence from a large, multicentre retrospective study from Italy
8. Primary sclerosing cholangitis recurrence after liver transplantation: a nationwide survey in Italy
9. Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?
10. Nationwide survey of liver transplantation for Primary Sclerosing Cholangitis in Italy
11. Interferon-Free Regimens in Hepatitis B Surface Antigen/Anti–Hepatitis C Virus Positive Patients: The Need to Control Hepatitis B Virus Replication to Avoid Hepatitis B Virus Reactivation
12. Safety and effectiveness of sorafenib in patients with hepatocellular carcinoma in clinical practice
13. Telbivudin as Prophylaxis for Hepatitis B Virus Recurrence After Liver Transplantation: A Case Series in Single-Center Experience
14. Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a
15. Humoral response to 2-dose BNT162b2 mRNA vaccine for COVID-19 in liver transplant recipients
16. The IMPROVEMENT project: first report of the global liver transplant activity
17. Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection
18. Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: A randomized trial
19. Covid-19 in Liver Transplant Recipients: An Italian Case-Control Double-Centre Study.
20. Modulation of cytokine and β-defensin 2 expressions in human gingival fibroblasts infected with Chlamydia pneumoniae
21. Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation
22. Pregnancy after liver transplantation: a survey from Italian liver transplants centres
23. THU-527 - Primary sclerosing cholangitis recurrence after liver transplantation: a nationwide survey in Italy
24. OS-069 - Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: risk of HCC recurrence from a large, multicentre retrospective study from Italy
25. Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
26. Subcutaneous Anti-Hepatitis B Immunoglobulins (ZutectraTM) after Liver Transplantation: An Interim Analysis of a Multicenter, Prospective, Single-Arm Study.: Abstract# O-131
27. TACROLIMUS ONCE DAILY (Advagraf) VERSUS TWICE DAILY (Prograf) IN LIVER TRANSPLANTED PATIENTS: AN OBSERVATIONAL SINGLE-CENTRE STUDY: RO-189
28. CONVERSION TO SUBCUTANEOUS ANTI-HEPATITIS B IMMUNOGLOBULINS (Zutectra™) IN MAINTENANCE LIVER TRANSPLANT PATIENTS: PRELIMINARY RESULTS OF A MULTICENTER, PROSPECTIVE, SINGLE-ARM STUDY: RO-151
29. Chlamydia pneumoniae induces interleukin-6 and interleukin-10 in human gingival fibroblasts
30. SAT233 - Humoral response to 2-dose BNT162b2 mRNA vaccine for COVID-19 in liver transplant recipients
31. P.04.14 HEPATOCELLULAR CARCINOMA AND SMOKING ARE INDEPENDENT RISK FACTORS FOR DEVELOPMENT OF DE-NOVO EXTRAHEPATIC TUMORS IN LIVER TRANSPLANT RECIPIENTS
32. THE C282Y MUTATION IN A GROUP OF PATIENTS WITH HEREDITARY HEMOCROMATOSIS IN SOUTHERN ITALY
33. PROGNOSTIC FACTORS IN HEPATOCELLULAR CARCINOMA (HCC) IN CIRRHOTICS TREATED BY PERCUTANEOUS ETHANOL INJECTION (PEI)
34. INTERFERON plus RIBAVIRIN vs INTERFERON ALONE IN HCV CHRONIC LIVER DISEASE NON RESPONDER TO A PREVIOUS CYCLE OF INTERFERON ALONE
35. RECOMBINANT vs LEUCOCYTIC INTERFERON IN THE TREATMENT OF HCV CHRONIC LIVER DISEASE: FINAL REPORT OF A RANDOMIZED CONTROLLED TRIAL
36. Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment
37. Linee di Gestione per l'immunosoppressione nel paziente adulto trapiantato di fegato - Aggiornamento 2022: Percorso delle attività dei Gruppi di Lavoro e raggiungimento del Consenso da parte del Panel di Esperti dei Centri Italiani.
38. Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?
39. Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?
40. Sa1872 Biomolecolar Markers Fail to Assist the Prognostic Evaluation of Hepatocellular Carcinoma
41. Sorafenib off-target effects predict outcomes in patients treated for hepatocellular carcinoma
42. IL BALTICO, DESTINAZIONE EMERGENTE NEL MERCATO CROCIERISTICO: ATTORI, PORTI E LINEE DI TENDENZA.
43. 194 ANTI-HBV IMMUNOPROPHYLAXIS IN LIVER TRANSPLANTED PATIENTS USING SUBCUTANEOUS ADMINISTRATION OF HBIG: PRELIMINARY RESULTS OF AN ONGOING OBSERVATIONAL STUDY
44. 414 PEG-INTERFERON PLUS RIBAVIRIN TREATMENT DOES NOT IMPROVE RECURRENCE AFTER RESECTION OR ABLATION OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS: A CASE-CONTROL STUDY
45. P.1.1: PREDICTIVE FACTORS FOR TUMOR CONTROL AMONG HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH SORAFENIB
46. OC.10.1: RADIOFREQUENCY ABLATION VERSUS LASER ABLATION FOR THE TREATMENT OF SMALL HEPATOCELLULAR CARCINOMA: A RANDOMIZED CONTROLLED TRIAL
47. P.1.66: SAFETY AND EFFECTIVENESS OF TREATMENT WITH SORAFENIB IN ELDERLY CIRRHOTIC PATIENTS AFFECTED BY ADVANCED HEPATOCELLULAR CARCINOMA
48. P.1.97: SORAFENIB FOR THE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA: EFFECTIVENESS AND IMPACT OF ADVERSE EFFECTS IN DAILY CLINICAL PRACTICE
49. OC-28 Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma: A randomized controlled trial
50. T-41 Sorafenib for the treatment of advanced hepatocellular carcinoma: Effectiveness and impact of adverse effects in daily clinical practice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.